Steward Partners Investment Advisory, LLC Mainz Biomed N.V. Transaction History

Steward Partners Investment Advisory, LLC

  • $11 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.2 - $0.48 $5,800 - $13,920
29,000 New
29,000 $7,000
Q4 2022

Feb 15, 2023
BUY
$6.31 - $9.38 $9,465 - $14,070
1,500 New
1,500 $10,000

Others Institutions Holding MYNZ

# of Institutions
1
Shares Held
10.9K
Call Options Held
0
Put Options Held
0
View Full List

About MAINZ BIOMED N.V.

MYNZ Quotes by TradingView
  • Ticker MYNZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 14,483,000
  • Market Cap $83.1M
  • Description
  • Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments...
More about MYNZ
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email